In vitro susceptibility of Trichomonas vaginalis to AT-specific minor groove binding drugs

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 2, 2003, Pages 287-289

  Chavalitshewinkoon Petmitr, Porntip ^a   Ramdja, Muhaimin ^a   Kajorndechakiat, Somsri ^a   Ralph, Raymond K ^b   Denny, William A ^c   Wilairat, Prapon ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d NONE   (Thailand)

Author keywords

AT specific drugs; DNA minor groove; Trichomonas vaginalis

Indexed keywords

4 [4 [4 [4(N METHYLQUINOLINIUM)AMINO]BENZAMIDO]ANILINO] N METHYLPYRIDINUM; ADENINE; ANTITRICHOMONAL AGENT; DNA; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SN 6999; THYMINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; AT RICH SEQUENCE; BASE PAIRING; CONTROLLED STUDY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS;

ANIMALS; BASE PAIRING; DNA-BINDING PROTEINS; DRUG RESISTANCE; HUMANS; PROTEIN BINDING; QUINOLINIUM COMPOUNDS; TRICHOMONAS VAGINALIS;

EID: 0042028106     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg322     Document Type: Article

References (10)

1. Lossick, J. G. (1990). Treatment of urogenital trichomoniasis. In Trichomonads Parasitic in Human (Honigberg, B. M., Ed), pp. 324-41. Springer Verlag, New York, NY, USA.
2. Quon, D. V., d'Oliveira, C. E. & Johnson, P. J. (1992). Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proceedings of the National Academy of Sciences, USA 89, 4402-6.
3. Zimmer, C. & Wannert, U. (1986). Nonintercalating DNA binding ligands: specificity of the interaction and their use as tool in biophysical, biochemical and biological investigation of the genetic material. Progress in Biophysics and Molecular Biology 47, 32-112.
4. Turner, P. R. & Denny, W. A. (2000). The genome as a drug target: sequence specific minor groove binding ligands. Current Drug Targets 1, 1-14.
5. Chen, A. Y., Yu, C., Batto, B. et al. (1993). DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proceedings of the National Academy of Sciences, USA 90, 8131-5.
6. Cain, B. F., Atwell, G. J. & Seelyne, R. N. (1969). Potential antitumor agents. X. Bisquaternary salts. Journal of Medicinal Chemistry 12, 199-206.
7. Mandel, M. & Honigberg, B. M. (1964). Isolation and characterization of deoxyribonucleic acid of two species of Trichomonas Donne. Journal of Protozoology 11, 114-6.
8. Hollander, D. H. (1976). Colonial morphology of Trichomonas vaginalis in agar. Journal of Parasitology 62, 826-8.
9. Atwell, G. J. & Cain, B. F. (1974). Potential antitumour agents. 15. Bisquaternary salts. Journal of Medicinal Chemistry 17, 930-4.
10. Atwell, G. J. & Cain, B. F. (1973). Potential antitumor agents. 13. Bisquaternary salts. Journal of Medicinal Chemistry 16, 673-8.